The landscape of fill/finish for mRNA vaccines presents unique challenges for CDMOs. These challenges include the need for capabilities to formulate and supply lipid nano particles (LNP) for mRNA encapsulation, as well as the criticality of cryo-handling. CDMOs face the additional complexity of meeting seasonal availability requirements for mRNA vaccines, which contrasts with steady monthly […]